These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12521973)

  • 1. Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia.
    Friend M; Vucenik I; Miller M
    BMJ; 2003 Jan; 326(7380):82-3. PubMed ID: 12521973
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperlipidaemia and cardiovascular disease.
    Sussekov AV
    Curr Opin Lipidol; 1999 Dec; 10(6):635-9. PubMed ID: 10680059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resistance to antiplatelet drugs in patients with non ST elevation acute coronary syndrome].
    Aĭnetdinova DKh; Udovichenko AE; Sulimov VA
    Kardiologiia; 2008; 48(6):35-9. PubMed ID: 18729834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between reduced aspirin responsiveness as assessed by impedance aggregometry and adverse outcomes after cardiac surgery: methodological considerations.
    Petricevic M; Madzar T; Rotim C; Biocina B
    Platelets; 2016 Jul; 27(5):492-4. PubMed ID: 26836458
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
    Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
    J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein analysis.
    Colyar MR
    Adv Nurse Pract; 2002 May; 10(5):30-2. PubMed ID: 12420528
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
    Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
    Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA; Savenkov MP
    Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.
    Lee PY; Chen WH; Ng W; Cheng X; Kwok JY; Tse HF; Lau CP
    Am J Med; 2005 Jul; 118(7):723-7. PubMed ID: 15989905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of aspirin resistance in type 2 diabetes.
    Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
    J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance after coronary artery bypass grafting.
    Zimmermann N; Kienzle P; Weber AA; Winter J; Gams E; Schrör K; Hohlfeld T
    J Thorac Cardiovasc Surg; 2001 May; 121(5):982-4. PubMed ID: 11326244
    [No Abstract]   [Full Text] [Related]  

  • 20. Low Levels of High-Density Lipoprotein Cholesterol Are Linked to Impaired Clopidogrel-Mediated Platelet Inhibition.
    Wadowski PP; Lee S; Kopp CW; Koppensteiner R; Panzer S; Gremmel T
    Angiology; 2018 Oct; 69(9):786-794. PubMed ID: 29482349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.